Login or Register to make a submission.

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Guidelines for Authors

Urban Disease Prevention and Control Institute Journal

Scope of the Journal and Article Types

The Urban Disease Prevention and Control Institute Journal welcomes academic articles and research reports related to diseases and health hazards, as well as works on disease prevention and control. Submitted manuscripts must not have been published previously or be under consideration for publication in any other journal. The editorial board reserves the right to review and edit manuscripts and will consider publication based on the suitability and the order of submission.

Manuscript Submission

The Urban Disease Prevention and Control Institute Journal is an academic journal aimed at disseminating research publications, including:

  • Original articles

  • Review articles

  • Perspectives or opinions

  • Case reports

  • Miscellany or letters to the editor

Submitted manuscripts must not have been published or under consideration elsewhere. The editorial board reserves the right to review, edit, and consider manuscripts for publication in order of submission.

The editorial board will notify authors upon acceptance of manuscripts. Manuscripts not accepted for publication will be informed, but original documents will not be returned.

Publication Schedule
Twice annually:

  • Issue 1: January – June

  • Issue 2: July – December

Manuscript Submission Deadlines

  • Issue 1: by April

  • Issue 2: by October

Publication Fees

No fees are charged at any stage of the publication process.

Ethical Guidelines for Authors

Adherence to Ethical Standards

Authors must demonstrate compliance with research ethics. Ethical considerations must be included in the Methods section, including approval from an ethics committee and informed consent procedures for human studies. Research involving human participants must adhere to the Declaration of Helsinki (2008). Authors must provide the approved research project number from the ethics committee, along with references to laboratory standards or other relevant guidelines if applicable.

Original research involving humans must have approval from an ethics committee. Authors must include the project approval number, committee name, affiliated institution, and describe the consent process from participants.

Human research testing medical products (e.g., drugs, medical devices, food supplements, or medical procedures) constitutes clinical trials and must be registered in a clinical trial registry such as ClinicalTrials.gov.

Animal research must have approval from an animal research ethics committee, and details (committee name, reference number, etc.) must be provided.

Plagiarism

All submissions are screened for plagiarism through the Thaijo system. Academic papers must not exceed 30% similarity, and research papers must not exceed 25%.

Manuscript Preparation

Language

Manuscripts may be written in Thai or English. For Thai articles, tables, figures, and references must be in Thai. For English articles, titles, author names, abstracts, and keywords must also be in English.

Formatting

  • Margins: 2.54 cm on all sides

  • Thai manuscripts: Cordia font, size 14, single line spacing

  • English manuscripts: Cordia font, size 14, 0 line spacing

Word Count

  • Original and Review Articles: Thai 3,500–4,500 words; English 2,500–3,500 words; up to 5 tables/figures

  • Perspectives, Opinions, and Case Reports: Thai 1,600–2,400 words; English 1,200–1,800 words; up to 3 tables/figures

  • Miscellany: Thai ≤2,400 words; English ≤1,800 words

  • Letters to the Editor: Thai ≤1,500 words; English ≤1,100 words

Article Structure

Original Articles: Title page, English abstract & keywords, Thai abstract & keywords (for Thai manuscripts), Introduction, Materials & Methods, Results, Discussion, Conclusion, References, Tables/Figures with captions.

Review Articles: Narrative reviews may be flexible; systematic reviews should follow PRISMA guidelines.

Perspectives & Opinions: Should present viewpoints or experiences in public health, supported by evidence. Structure: background, analysis, discussion of strengths/limitations, and conclusions.

Case Reports: Reports of unusual cases or new/rare conditions with clear documentation. Include Introduction, Case Description, Discussion/Observations, References.

Miscellany: Short articles not fitting other categories, e.g., brief reports, clinical notes, or preliminary studies.

Letters to the Editor: Responses to previously published articles, addressing discrepancies or errors. Begin with “Dear Editor,” end with author name, academic position, and affiliation; references ≤15.

Title Page

Include concise title, author names with superscript numbers for affiliations, and corresponding author contact details (address, email, phone). Include research ethics, author contributions, acknowledgments, funding sources, and conflicts of interest.

Abstract & Keywords

  • Original & Review Articles: Thai abstract ≤300 words, extended English abstract 500–600 words. Include key points: objectives, methods, results, discussion/recommendations.

  • English articles: English abstract ≤250 words. List 3–5 keywords under each abstract.

Main Text

Original Articles: Introduction, objectives, methods (data sources, collection, sampling, research tools, statistical analysis), results with evidence, discussion with references, limitations/strengths, conclusions, and recommendations.

Review Articles: State novelty and rationale. Include overview, research gaps, neutral and balanced presentation.

Systematic Reviews: Follow PRISMA guidelines.

Perspectives: Novel insights on public health issues, supported by evidence. Include background, interpretation, discussion, and conclusions.

Opinions: Author’s viewpoints on public health theory or hypotheses, supported by reliable references or personal expertise, to stimulate academic discussion.

Tables & Figures

  • Must be in English, Cordia New font, size 14

  • Referenced in text: (Table 1), (Figure 1), etc.

  • Columns/rows clearly labeled with units; use “n” and “%” for sample size and percentages

  • Decimal points: 1 for percentages, 2 for means and SD

  • Footnotes: superscript letters (a, b, c), no asterisks (*, **)

Figures may include charts, illustrations, photos, etc. Charts should be created using software (MS Excel, GraphPad, etc.). Photos in JPEG or TIFF format. Word figures may be DOC/DOCX. Minimum resolution: 600 dpi (B/W), 1200 dpi (color).

Author Contributions

All authors must contribute according to ICMJE guidelines: ICMJE Author Roles

Funding Disclosure

State funding sources and the role of funders. If none, indicate: “No funding was received” or “The author funded this study independently.”

Conflict of Interest

Declare any personal or institutional relationships that may influence study outcomes.

Acknowledgments

Acknowledge contributors who are not authors in a single paragraph.

References

Use Vancouver style. Cite references in text as superscript (1, 2, 3). For non-English references, indicate the language in parentheses. For more than six authors, list the first six followed by “et al.” Journal names may be abbreviated per Index Medicus/NLM.

Contact

Urban Disease Prevention and Control Institute
24/56 Phahonyothin Road, Anusawari, Bangkhen, Bangkok 10220, Thailand
Tel: +66 2 972 9606 #2301-3
E-mail: training10iudc@gmail.com